Cassava Sciences Inc SAVA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EST
49.50quote price arrow up+0.92 (+1.89%)
Volume
27,942
Close
48.58quote price arrow down-2.30 (-4.52%)
Volume
2,215,582
52 week range
1.63 - 117.54

...

Loading . . .

KEY STATS

  • Open51.10
  • Day High52.00
  • Day Low47.79
  • Prev Close50.88
  • 52 Week High117.54
  • 52 Week High Date02/04/21
  • 52 Week Low1.63
  • 52 Week Low Date05/15/20
  • Market Cap1.441B
  • Shares Out29.66M
  • 10 Day Average Volume5.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • 1 Year % Change655.52

RATIOS/PROFITABILITY

  • EPS (TTM)-0.23
  • P/E (TTM)-207.96
  • Fwd P/E (NTM)-117.91
  • EBITDA (MRQ)-5.709M
  • ROE (MRQ)-25.26%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/10/2021
  • Ex Div Date12/13/2010
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest Cassava Sciences Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cassava Sciences, Inc., formerly Pain Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing drug for the treatment of nervous system disorders. The Company is ocused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer’s. Its drug candidate, PTI-125, is a small molecule that targets an altered form of a scaffolding protein called filamin A (FLNA). The Company is also developing an experimental...
Remi Barbier
Chairman
Nadav Friedmann M.D., Ph.D.
Chief Operating Officer
Eric Schoen
Chief Financial Officer
Address
7801 N Capital of Texas Hwy Ste 260
Austin, TX
78731-1192
United States